Nktx stock forecast.

Nkarta (NASDAQ:NKTX) is a biopharmaceutical company that develops engineered natural killer (NK) cell therapies to treat cancer.NK cells are a type of immune cell that can recognize and kill tumor ...

Nktx stock forecast. Things To Know About Nktx stock forecast.

When Nkarta last reported its balance sheet in June 2022, it had zero debt and cash worth US$413m. Looking at the last year, the company burnt through US$78m. That means it had a cash runway of ...Stock Price Forecast The 5 analysts offering 12-month price forecasts for IO Biotech Inc have a median target of 10.00, with a high estimate of 15.00 and a low estimate of 7.00. About the Nkarta, Inc. stock forecast. As of 2023 October 17, Tuesday current price of NKTX stock is 1.495$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).Find the latest Elastic N.V. (ESTC) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...

Nkarta, Inc. Stock Earnings. The value each NKTX share was expected to gain vs. the value that each NKTX share actually gained. Nkarta, Inc. ( NKTX) reported Q3 2023 earnings per share (EPS) of -$0.52, beating estimates of -$0.67 by 22.07%. In the same quarter last year, Nkarta, Inc. 's earnings per share (EPS) was -$0.58.

Nkarta Inc (NKTX) Company Description. Nkarta Inc is a biopharmaceutical company developing engineered natural killer (NK) cells to fight cancer. The company is focused on leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable.

Oct 2, 2023 · NKTX Stock Predictions, Articles, and Nkarta Inc News ... NKTX stock is a fast mover, and a recent share-price bump came in the wake of exciting data from a "killer cell" anti-cancer research program. Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Wall Street Analysts Predict a 209% Upside in Nkarta, Inc. (NKTX): Here's What You Should Know. 06/07/22-8:55AM EST Zacks.Nov 30, 2023 · Price Target Based on short-term price targets offered by seven analysts, the average price target for Nkarta, Inc. comes to $12.57. The forecasts range from a low of $9.00 to a high of $15.00.... Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...

Mar 20, 2023 · SVB Securities analyst Daina Graybosch maintained a Buy rating on Nkarta (NKTX – Research Report) today.The company’s shares opened today at $3.76. According to TipRanks, Graybosch is an ...

Nextracker last posted its quarterly earnings data on October 25th, 2023. The reported $0.55 EPS for the quarter, beating analysts' consensus estimates of $0.30 by $0.25. The firm had revenue of $573.36 million for the quarter, compared to the consensus estimate of $547.24 million. Nextracker has generated $0.00 earnings per share over the …

(NKTX) reported a total revenue of $25 million. The company's net income for ... As of 2023, the company's stock price is $45 per share. When analyzing the ...Nkarta has generated ($2.50) earnings per share over the last year ( ($2.50) diluted earnings per share). Earnings for Nkarta are expected to grow in the coming year, from ($2.50) to ($2.42) per share. Nkarta has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 21st, 2024 ... Stock Price Forecast The 19 analysts offering 12-month price forecasts for Illumina Inc have a median target of 125.00, with a high estimate of 260.00 and a low estimate of 50.00.TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comView real-time stock prices and stock quotes for a full financial overview. ... AMC Stock Outlook: Billionaire Bails, But Does a Comeback Beckon? May. 24, 2023 at 1:20 p.m. ET ...

TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the ...Find the latest Gamida Cell Ltd. (GMDA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Oct. 18, 2023, 08:00 AM Analysts have provided the following ratings for Nkarta (NASDAQ:NKTX) within the last quarter: In the last 3 months, 7 analysts have offered 12 …$2.72 +0.0800 (+3.03%) At Close: Dec 01, 2023 Real-time prices appear during market hours U.S. markets are closed | Score: 4.99 Strong Sell Hold Strong Buy …The average Barrick Gold stock price prediction forecasts a potential upside of 31.13% from the current GOLD share price of $17.73. What is GOLD's forecast return on equity (ROE) for 2023-2026? (NYSE: GOLD) forecast ROE is N/A, which is considered weak.

Dec 1, 2023 · Valuation metrics show that Nkarta, Inc. may be fairly valued. Its Value Score of C indicates it would be a neutral pick for value investors. The financial health and growth prospects of NKTX ... What Caused Applied Therapeutics (APLT) Stock to Rise 23% Pre-Market? After announcing a substantial agreement, Applied Therapeutics Inc. (NASD: APLT) has increased 23.01% to $0.9253 in pre-market trading …

Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Fisker Inc have a median target of 4.50, with a high estimate of 11.00 and a low estimate of 2.00. The median estimate ...Nkarta Inc (NKTX) Company Description. Nkarta Inc is a biopharmaceutical company developing engineered natural killer (NK) cells to fight cancer. The company is focused on leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.We would like to show you a description here but the site won’t allow us.27 thg 6, 2023 ... The pharmaceutical stock dropped after announcing so-so clinical trial results.Find the latest Sunshine Biopharma, Inc. (SBFM) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...Find the latest SEC Filings data for Nkarta, Inc. Common Stock (NKTX) at Nasdaq.com.

The consensus price target of analysts on Wall Street is $14.13, which implies an increase of 80.75% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $9.00 and $25.00 respectively. As a result, NKTX is trading at a discount of -819.12% off the target high and -230.88% off the low.

What is Nkarta's Market Cap? ( NASDAQ: NKTX) Nkarta 's market cap is $127.10M, as of Nov 24, 2023. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Nkarta 's market cap is calculated by multiplying NKTX 's current stock price of $2.59 by NKTX 's total outstanding shares of.

Acumen Pharmaceuticals Inc. 2.37. +0.01. +0.42%. Get Nkarta Inc (NKTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.Mar. 20, 2023, 08:47 AM. SVB Securities analyst Daina Graybosch maintained a Buy rating on Nkarta ( NKTX – Research Report) today. The company’s shares opened today at $3.76. According to ...We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...Jun 27, 2023 · On June 22, six executives sold a total of 4,033 shares of Nkarta, including CEO Paul Hastings, who sold 1,704. While company insiders often sell stock for various reasons, the timing of the sales ... A high-level overview of Nkarta, Inc. (NKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Since the start of the year, NKTX lost 77% of its equity value. However, in sharp contrast to the market performance, analysts rate NKTX a unanimous strong buy. Their average price target lands at ...NKTX Earnings Forecast. Next quarter’s earnings estimate for NKTX is -$0.59 with a range of -$0.96 to -$0.40. The previous quarter’s EPS was -$0.52. NKTX beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 59.59% of the time in the same period.

US$296.82m. Market Cap. US$128.57m. NKTX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA. Key Statistics. Enterprise Value/Revenue. n/a. Enterprise Value/EBITDA.Apr 25, 2022 · On March 17, the company reported an earnings loss of 69 cents per share, which did beat the Thomson Reuters forecast of a loss of 75 cents. Research analysts expect Nkarta will post a loss of $3. ... Valuation metrics show that Nkarta, Inc. may be fairly valued. Its Value Score of C indicates it would be a neutral pick for value investors. The financial health and growth prospects of NKTX ...Instagram:https://instagram. auton zonelpeninstacart ipo share pricei need 1 000 dollars now Nkarta, Inc. SOUTH SAN FRANCISCO, Calif., April 25, 2022 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer cell therapies to treat ... martini incentivesliberty dimes worth money Stock Price Forecast The 12 analysts offering 12-month price forecasts for C3.ai Inc have a median target of 27.50, with a high estimate of 42.00 and a low estimate of 14.00.To conclude, with market capitalization of $415M and EV of ~$20M, my conclusion is that Nkarta is a logical purchase as valuation is at lows, data to date has been promising and additional updates ... how much is a susan b anthony worth Find real-time BEAM - Beam Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.Nkarta Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NKTX updated stock price target summary. ... Stock Price Target NKTX. High $ 25.00: Median $ 14.00: Low $ 9.00 ...